The guidance includes recommendations for extended RAS mutation testing to guide anti-EGFR therapy, as well as updated endorsements for analysis of mismatch repair status.
University of Cambridge researchers found that the portion of tumor DNA in patients' blood could predict treatment response and time to disease progression.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
A member of the committee issuing a blunt report on the inadequacy of biomarker-based testing speaks about what the next Secretary of HHS needs to do.
Caris Life Sciences also found that time-to-next treatment could be a surrogate endpoint for survival.
Groups receiving funding will be part of a Consortium for Imaging and Biomarkers to perform collaborative studies, share ideas, and leverage common resources.
Georgia Tech researchers used high-performance mass spectrometry to uncover a highly accurate 16-marker signature that identifies women with ovarian cancer.
Amarantus will use its LymPro Test to evaluate the pharmacodynamic effect of Anavex 2-73 and Anavex Plus on the expression of the biomarker CD69.
Abbott is looking to develop molecular and companion diagnostic assays based on mutations in the FGFR3 gene, which are found in many early stage bladder cancers.
Exiqon announces an exclusive agreement with Aarhus University Hospital to license prostate cancer biomarkers discovered and validated by the hospital.
The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.
The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.
Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.
In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.